A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'

被引:0
|
作者
Gao, Fengwei [1 ,2 ,3 ]
Zhao, Xin [4 ]
Xie, Qingyun [4 ]
Yang, Jiayin [1 ,2 ,3 ]
Wu, Hong [1 ,2 ,3 ,5 ]
机构
[1] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
[4] Peoples Hosp Leshan, Dept Hepatopancreatobiliary Surg, Leshan, Peoples R China
[5] Liver Transplantat Ctr, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
关键词
D O I
10.1097/JS9.0000000000001052
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:2442 / 2443
页数:2
相关论文
共 50 条
  • [31] Role of preoperative transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma (Hong Kong liver cancer stage IIB)
    Nandy, Kunal
    Varty, Gurudutt P.
    Patkar, Shraddha
    Shah, Tanvi
    Gundavda, Kaival
    Gala, Kunal
    Shetty, Nitin
    Kulkarni, Suyash
    Goel, Mahesh
    WORLD JOURNAL OF SURGERY, 2025, 49 (02) : 483 - 493
  • [32] Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
    Ashour, Reham
    Rewisha, Eman
    Rady, Mohamed A. K. L.
    Elkhadry, Sally Waheed
    Abdelhalim, Heba
    Atef, Mohamed
    BMC CANCER, 2024, 24 (01)
  • [33] A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
    Jia-yan Ni
    Zhu-ting Fang
    Hong-liang Sun
    Chao An
    Zhi-mei Huang
    Tian-qi Zhang
    Xiong-ying Jiang
    Yao-ting Chen
    Lin-feng Xu
    Jin-hua Huang
    European Radiology, 2020, 30 : 2377 - 2390
  • [34] Lenvatinib prolongs the progression-free survival time of patients with intermediate-stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis
    Shimose, Shigeo
    Kawaguchi, Takumi
    Tanaka, Masatoshi
    Iwamoto, Hideki
    Miyazaki, Ken
    Moriyama, Etsuko
    Suzuki, Hiroyuki
    Niizeki, Takashi
    Shirono, Tomotake
    Nakano, Masahito
    Suga, Hideya
    Yamaguchi, Taizo
    Yokokura, Yoshinori
    Noguchi, Kazunori
    Koga, Hironori
    Torimura, Takuji
    ONCOLOGY LETTERS, 2020, 20 (03) : 2257 - 2265
  • [35] A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
    Ni, Jia-yan
    Fang, Zhu-ting
    Sun, Hong-liang
    An, Chao
    Huang, Zhi-mei
    Zhang, Tian-qi
    Jiang, Xiong-ying
    Chen, Yao-ting
    Xu, Lin-feng
    Huang, Jin-hua
    EUROPEAN RADIOLOGY, 2020, 30 (04) : 2377 - 2390
  • [36] Transarterial chemoembolizaton combined with sorafenib for intermediate-stage hepatocellular carcinoma: a window of tumor burden for survival benefit
    Wang, E.
    Bai, W.
    Xia, D.
    Liu, L.
    Wang, W.
    Chen, H.
    Wang, Q.
    Zuo, L.
    Lv, Y.
    Liu, H.
    Yin, Z.
    Xia, J.
    Fan, D.
    Han, G.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S219 - S219
  • [37] Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study
    Fu, Sirui
    Wei, Jingwei
    Zhang, Jie
    Dong, Di
    Song, Jiangdian
    Li, Yong
    Duan, Chongyang
    Zhang, Shuaitong
    Li, Xiaoqun
    Gu, Dongsheng
    Chen, Xudong
    Hao, Xiaohan
    He, Xiaofeng
    Yan, Jianfeng
    Liu, Zhenyu
    Tian, Jie
    Lu, Ligong
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10
  • [38] Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ferreira-Silva, Joel
    Costa-Moreira, Pedro
    Cardoso, Helder
    Liberal, Rodrigo
    Pereira, Pedro
    Macedo, Guilherme
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2023, 30 (01) : 29 - 37
  • [39] Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study
    Kuo, Li-Fu
    Liu, Wen-Chun
    Li, Ming-Feng
    Huang, Fu-Huan
    Chou, Chu-Kuang
    Chen, Tsung-Hsien
    Tsai, Yi-Tseng
    Hsu, Ping-I.
    Li, Chao-Jen
    Wu, I. -Ting
    Tsai, Kun-Feng
    ONCOLOGY, 2024,
  • [40] Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
    Peng, Jie
    Huang, Jinhua
    Huang, Guijia
    Zhang, Jing
    FRONTIERS IN ONCOLOGY, 2021, 11